Concerns Grow as FDA Drug Center Head Tracy Beth Høeg Resigns

← SIGNALS[LIFE]
Concerns Grow as FDA Drug Center Head Tracy Beth Høeg ResignsTracy Beth Høeg's resignation from the FDA's drug center follows the recent departure of Commissioner Marty Makary, highlighting a troubling leadership gap within the agency.
Editorial Staff / May 15, 2026 / 1 MIN READ

Tracy Beth Høeg, the acting director of the FDA’s drug center, has announced her resignation, which took effect on May 15, 2026.

Her departure comes shortly after Commissioner Marty Makary resigned, raising alarms about the stability of leadership at the FDA.

This leadership vacuum occurs at a critical juncture for the agency, as it navigates ongoing challenges in the healthcare sector.